JPMorgan cut its recommendation on the stock to “Underweight” from “Neutral” and withdrew its price target.Finance, news, Silvergate Bank, JPMorganRead More

You might also be interested in reading Bayer hot flashes therapy for breast cancer patients hits main goal in late-stage trial.